Stock AGTC APPLIED GENETIC TECHNOLOGIES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders Applied Genetic Technologies Corporation

Equities

AGTC

US03820J1007

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Applied Genetic Technologies Corporation Announces Executive Appointments
CI
Ivana Magovcevic-Liebisch Resigns from Board of Directors and Each Committee of Which She Was A Member of Applied Genetic Technologies Corporation, Effective March 9, 2022
CI
Applied Genetic Technologies Corporation Appoints James Robinson as Board of Directors
CI
Applied Genetic Technologies Corporation Appoints Abraham Scaria, as Chief Science Officer
CI
Applied Genetic Technologies Corporation Appoints Hope DOyley-Gay as General Counsel
CI
Applied Genetic Technologies : Names New Chief Medical Officer
MT
Applied Genetic Technologies Corporation Appoints Susan Schneider, M.D., as Chief Medical Officer
CI
Applied Genetic Technologies Corporation Appoints Yehia Hashad to the Board of Directors
CI
Applied Genetic Technologies Corporation Announces the Appointment of Janet C. Rae, as Senior Vice President of Global Regulatory and Quality, Effective June 18, 2021
CI
Mark Shearman Resigns as Chief Scientific Officer of Applied Genetic Technologies Corporation
CI
Applied Genetic Technologies Corporation Announces Departure of Theresa Heah as Chief Medical Officer
CI
Applied Genetic Technologies Corporation Announces New Leadership Appointments
CI
Applied Genetic Technologies Corporation Appoints William Aliski to the Board of Directors
CI
Applied Genetic Technologies Corporation Appoints Lanita C. Scott as Vice President of Clinical Research and Medical Affairs and Karen M. Carroll as Vice President of Clinical Development Operations
CI
Applied Genetic Technologies Corporation Announces Resignation of R. Guyer from the Board
CI
Applied Genetic Technologies Corporation Appoints Matthew Feinsod, M.D. as Interim Chief Medical Officer
CI
Applied Genetic Technologies Corporation Announces the Resignation of Arnold L. Oronsky from the Board of Directors
CI
AGTC Appoints William Sullivan as Chief Financial Officer, Andrew Ashe Named General Counsel
GL
Applied Genetic Technologies Corporation Announces Executive Changes
CI
AGTC Announces Executive Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AGTC Stock
  4. News Applied Genetic Technologies Corporation
  5. Insiders